Local drug delivery of alendronate gel for the treatment of patients with chronic periodontitis with diabetes mellitus: A double-masked controlled clinical trial

Journal of Periodontology

Volumn 83, Issue 10, 2012, Pages 1322-1328

  Pradeep, A R ^a   Sharma, Anuj ^a   Rao, Nishanth S ^a   Bajaj, Pavan ^a   Naik, Savitha B ^a   Kumari, Minal ^a  

^a GOVERNMENT DENTAL COLLEGE AND RESEARCH INSTITUTE   (India)

Author keywords

Alendronate; Bone regeneration; Chronic periodontitis; Diabetes mellitus; Regeneration

Indexed keywords

ALENDRONIC ACID; BONE DENSITY CONSERVATION AGENT;

ADULT; ALVEOLAR BONE LOSS; ARTICLE; BONE REGENERATION; CHEMISTRY; CHI SQUARE DISTRIBUTION; CHRONIC PERIODONTITIS; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DELIVERY SYSTEM; FEMALE; GEL; HUMAN; INTRALESIONAL DRUG ADMINISTRATION; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIODONTAL POCKET; PERIODONTICS; PROSPECTIVE STUDY; RADIOGRAPHY; RANDOMIZED CONTROLLED TRIAL; TOOTH PLAQUE;

ADULT; ALENDRONATE; ALVEOLAR BONE LOSS; BONE DENSITY CONSERVATION AGENTS; BONE REGENERATION; CHI-SQUARE DISTRIBUTION; CHRONIC PERIODONTITIS; CONFIDENCE INTERVALS; DENTAL PLAQUE INDEX; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; DRUG DELIVERY SYSTEMS; FEMALE; GELS; HUMANS; INJECTIONS, INTRALESIONAL; MALE; MIDDLE AGED; PERIODONTAL INDEX; PERIODONTAL POCKET; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84867169921     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2012.110292     Document Type: Article

References (43)

1. Salvi GE, Lang NP. Host response modulation in the management of periodontal diseases. J Clin Periodontol 2005;32(Suppl. 6):108-129.
2. Tatakis DN, Kumar PS. Etiology and pathogenesis of periodontal diseases. Dent Clin North Am 2005;49: 491-516, v.
3. Mealey BL, Oates TW. American Academy of Periodontology commissioned paper. Diabetes mellitus and periodontal diseases. J Periodontol 2006;77:1289-1303.
4. Mealey BL, Rose LF. Diabetes mellitus and inflammatory periodontal diseases. Curr Opin Endocrinol Diabetes Obes 2008;15:135-141.
5. Mangan D, Selwitz RH, Genco R. Infections associated with diabetes mellitus. N Engl J Med 2000;342:896.
6. BacićM, Plancak D, GranićM. CPITN assessment of periodontal disease in diabetic patients. J Periodontol 1988;59:816-822.
7. Emrich LJ, Shlossman M, Genco RJ. Periodontal disease in non-insulin-dependent diabetes mellitus. J Periodontol 1991;62:123-131.
8. Shlossman M, Knowler WC, Pettitt DJ, Genco RJ. Type 2 diabetes mellitus and periodontal disease. J Am Dent Assoc 1990;121:532-536.
9. Tervonen T, Oliver RC. Long-term control of diabetes mellitus and periodontitis. J Clin Periodontol 1993;20: 431-435.
10. Binderman I. Bone and biologically compatible materials in dentistry. Curr Opin Dent 1991;1:836-840.
11. Wozney JM. The bone morphogenetic protein family and osteogenesis. Mol Reprod Dev 1992;32:160-167.
12. Baylink DJ, Finkelman RD, Mohan S. Growth factors to stimulate bone formation. J Bone Miner Res 1993; 8(Suppl. 2):S565-S572.
13. Adami S, Zamberlan N, Mian M, et al. Duration of the effects of intravenous alendronate in postmenopausal women and in patients with primary hyperparathyroidism and Paget's disease of bone. Bone Miner 1994;25:75-82.
14. Liberman UA, Weiss SR, Bröll J, et al; The Alendronate Phase III Osteoporosis Treatment Study Group. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. N Engl J Med 1995;333:1437-1443.
15. Jeffcoat MK, Cizza G, Shih WJ, Genco R, Lombardi A. Efficacy of bisphosphonates for the control of alveolar bone loss in periodontitis. J Int Acad Periodontol 2007; 9:70-76.
16. El-Shinnawi UM, El-Tantawy SI. The effect of alendronate sodium on alveolar bone loss in periodontitis (clinical trial). J Int Acad Periodontol 2003;5:5-10.
17. Lane N, Armitage GC, Loomer P, et al. Bisphosphonate therapy improves the outcome of conventional periodontal treatment: Results of a 12-month, randomized, placebo-controlled study. J Periodontol 2005;76: 1113-1122.
18. Menezes AM, Rocha FA, Chaves HV, Carvalho CB, Ribeiro RA, Brito GA. Effect of sodium alendronate on alveolar bone resorption in experimental periodontitis in rats. J Periodontol 2005;76:1901-1909.
19. Reddy MS, Weatherford TW 3rd, Smith CA, West BD, Jeffcoat MK, Jacks TM. Alendronate treatment of naturally-occurring periodontitis in beagle dogs. J Periodontol 1995;66:211-217.
20. Weinreb M, Quartuccio H, Seedor JG, et al. Histomorphometrical analysis of the effects of the bisphosphonate alendronate on bone loss caused by experimental periodontitis in monkeys. J Periodontal Res 1994;29:35-40.
21. Yaffe A, Fine N, Alt I, Binderman I. The effect of bisphosphonate on alveolar bone resorption following mucoperiosteal flap surgery in the mandible of rats. J Periodontol 1995;66:999-1003.
22. Yaffe A, Fine N, Binderman I. Regional accelerated phenomenon in the mandible following mucoperiosteal flap surgery. J Periodontol 1994;65:79-83.
23. Reddy GT, Kumar TM, Veena KM. Formulation and evaluation of alendronate sodium gel for the treatment of bone resorptive lesions in periodontitis. Drug Deliv 2005;12:217-222.
24. Binderman I, Adut M, Yaffe A. Effectiveness of local delivery of alendronate in reducing alveolar bone loss following periodontal surgery in rats. J Periodontol 2000; 71:1236-1240.
25. Yaffe A, Iztkovich M, Earon Y, Alt I, Lilov R, Binderman I. Local delivery of an amino bisphosphonate prevents the resorptive phase of alveolar bone following mucoperiosteal flap surgery in rats. J Periodontol 1997;68: 884-889.
26. Wang HL, Weber D, McCauley LK. Effect of long-term oral bisphosphonates on implant wound healing: Literature review and a case report. J Periodontol 2007;78: 584-594.
27. Soileau KM. Oral post-surgical complications following the administration of bisphosphonates given for osteopenia related to malignancy. J Periodontol 2006;77:738-743.
28. Brägger U, Pasquali L, Kornman KS. Remodelling of interdental alveolar bone after periodontal flap procedures assessed by means of computer-assisted densitometric image analysis (CADIA). J Clin Periodontol 1988;15:558-564.
29. Wood DL, Hoag PM, Donnenfeld OW, Rosenfeld LD. Alveolar crest reduction following full and partial thickness flaps. J Periodontol 1972;43:141-144.
30. Sharma A, Pradeep AR. Clinical efficacy of 1% alendronate gel as local drug delivery system in the treatment of chronic periodontitis: A randomized controlled clinical trial. J Periodontol 2012;83:11-18.
31. Sharma A, Pradeep AR. Clinical efficacy of 1% alendronate gel in adjunct to mechanotherapy in the treatment of aggressive periodontitis: A randomized controlled clinical trial. J Periodontol 2012;83:19-26.
32. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2011; 34(Suppl. 1):S62-S69.
33. Mombelli A, van Oosten MA, Schurch E, Lang NP. The microbiota associated with successful or failing osseointegrated titanium implants. Oral Microbiol Immunol 1987;2:145-151.
34. Silness J, Löe H. Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition. Acta Odontol Scand 1964;22:121-135.
35. Pradeep AR, Sharma A. Autologous platelet-rich fibrin in the treatment of mandibular degree II furcation defects: A randomized clinical trial. J Periodontol. 2011;82: 1396-1403.
36. Rocha M, Nava LE, Vázquez de la Torre C, Sánchez- Márin F, Garay-Sevilla ME, Malacara JM. Clinical and radiological improvement of periodontal disease in patients with type 2 diabetes mellitus treated with alendronate: A randomized, placebo-controlled trial. J Periodontol 2001;72:204-209.
37. Brunsvold MA, Chaves ES, Kornman KS, Aufdemorte TB, Wood R. Effects of a bisphosphonate on experimental periodontitis in monkeys. J Periodontol 1992; 63:825-830.
38. Kinane DF. Local antimicrobial therapies in periodontal disease. Ann R Australas Coll Dent Surg 2000;15: 57-60.
39. Needleman IG, Pandya NV, Smith SR, Foyle DM. The role of antibiotics in the treatment of periodontitis (Part 2 - Controlled drug delivery). Eur J Prosthodont Restor Dent 1995;3:111-117.
40. Fleisch H. Bisphosphonates - Preclinical. In: Bisphosphonates in Bone Disease: From the Laboratory to the Patient. San Diego: Academic Press; 2000:34-55.
41. Jones DS, Brown AF, Woolfson AD. Rheological characterization of bioadhesive, antimicrobial, semisolids designed for the treatment of periodontal diseases: Transient and dynamic viscoelastic and continuous shear analysis. J Pharm Sci 2001;90:1978-1990.
42. Perioli L, Ambrogi V, Rubini D, et al. Novel mucoadhesive buccal formulation containing metronidazole for the treatment of periodontal disease. J Control Release 2004;95:521-533.
43. Jones DS, Woolfson AD, Djokic J, Coulter WA. Development and mechanical characterization of bioadhesive semi-solid, polymeric systems containing tetracycline for the treatment of periodontal diseases. Pharm Res 1996;13:1734-1738.